Literature DB >> 27230809

Pediatric Brain Tumors: An Update.

Devorah Segal1, Matthias A Karajannis2.   

Abstract

Brain tumors collectively represent the most common solid tumors in childhood and account for significant morbidity and mortality. Until recently, pediatric brain tumors were diagnosed and classified solely based on histologic criteria, and treatments were chosen empirically. Recent research has greatly enhanced our understanding of the diverse biology of pediatric brain tumors, their molecular and genetic underpinnings, leading to improved diagnostic accuracy and risk stratification, as well as the development of novel biomarkers and molecular targeted therapies. For subsets of patients, these new treatment options have already resulted in improved survival and decreased treatment toxicity. In this article, we provide an overview of the most common childhood brain tumors, describe recent key advances in the field, and discuss the therapeutic challenges that remain.
Copyright © 2016 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27230809     DOI: 10.1016/j.cppeds.2016.04.004

Source DB:  PubMed          Journal:  Curr Probl Pediatr Adolesc Health Care        ISSN: 1538-3199


  12 in total

1.  Clinicopathological features and microsurgical outcomes for giant pediatric intracranial tumor in 60 consecutive cases.

Authors:  Ailing Guo; Vigneyshwar Suresh; Xianzhi Liu; Fuyou Guo
Journal:  Childs Nerv Syst       Date:  2017-02-08       Impact factor: 1.475

Review 2.  Molecular Basis of Pediatric Brain Tumors.

Authors:  Alexia Klonou; Christina Piperi; Antonios N Gargalionis; Athanasios G Papavassiliou
Journal:  Neuromolecular Med       Date:  2017-07-26       Impact factor: 3.843

3.  Management and outcome of unusual pediatric brain tumors: challenges experienced at a tertiary care center of a developing country.

Authors:  Anand Kumar Das; Suraj Kant Mani; Saraj Kumar Singh; Subhash Kumar
Journal:  Childs Nerv Syst       Date:  2022-10-06       Impact factor: 1.532

4.  Initial symptoms and diagnostic delay in children with brain tumors at a single institution in Japan.

Authors:  Yuji Yamada; Daiki Kobayashi; Keita Terashima; Chikako Kiyotani; Ryuji Sasaki; Nobuaki Michihata; Toru Kobayashi; Hideki Ogiwara; Kimikazu Matsumoto; Akira Ishiguro
Journal:  Neurooncol Pract       Date:  2020-10-06

5.  The Role of Time as a Prognostic Factor in Pediatric Brain Tumors: a Multivariate Survival Analysis.

Authors:  Eduardo Javier Barragán-Pérez; Carlos Enrique Altamirano-Vergara; Daniel Eduardo Alvarez-Amado; Juan Carlos García-Beristain; Fernando Chico-Ponce-de-León; Vicente González-Carranza; Luis Juárez-Villegas; Chiharu Murata
Journal:  Pathol Oncol Res       Date:  2020-07-13       Impact factor: 2.874

Review 6.  Neuropilin-1: A Key Protein to Consider in the Progression of Pediatric Brain Tumors.

Authors:  Manon Douyère; Pascal Chastagner; Cédric Boura
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

7.  Deep Learning for Pediatric Posterior Fossa Tumor Detection and Classification: A Multi-Institutional Study.

Authors:  J L Quon; W Bala; L C Chen; J Wright; L H Kim; M Han; K Shpanskaya; E H Lee; E Tong; M Iv; J Seekins; M P Lungren; K R M Braun; T Y Poussaint; S Laughlin; M D Taylor; R M Lober; H Vogel; P G Fisher; G A Grant; V Ramaswamy; N A Vitanza; C Y Ho; M S B Edwards; S H Cheshier; K W Yeom
Journal:  AJNR Am J Neuroradiol       Date:  2020-08-13       Impact factor: 4.966

8.  The anti-asthmatic drug, montelukast, modifies the neurogenic potential in the young healthy and irradiated brain.

Authors:  Yohanna Eriksson; Martina Boström; Åsa Sandelius; Kaj Blennow; Henrik Zetterberg; Georg Kuhn; Marie Kalm
Journal:  Cell Death Dis       Date:  2018-07-10       Impact factor: 8.469

Review 9.  Intersection of Brain Development and Paediatric Diffuse Midline Gliomas: Potential Role of Microenvironment in Tumour Growth.

Authors:  Katie F Loveson; Helen L Fillmore
Journal:  Brain Sci       Date:  2018-11-16

10.  Myalgia and Hematuria in Association with Clonidine and Arginine Administration for Growth Hormone Stimulation Tests.

Authors:  Meghan Glibbery; Adam Fleming; Rahul Chanchlani; Olufemi Abiodun Ajani; Norma Marchetti; Alexa Marr; M Constantine Samaan
Journal:  Case Rep Med       Date:  2020-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.